Underwriters buy additional $658 mln in Teva Pharm shares


Jan 3 The underwriters for Teva Pharmaceutical Industries' share offering last month have exercised their over-allotment option to purchase additional shares worth $658 million. Teva, the world's biggest generic drugmaker, will use the funds to finance the cash portion of its planned $40.5 billion purchase of Allergan PLC's Actavis generics business.



from Biotech News